BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 9299179)

  • 1. Intravitreal Tissue Plasminogen Activator Injection for the Treatment of Proliferative Vitreoretinopathy in a Rabbit Model.
    Reitblat O; Barayev E; Gal-Or O; Tsessler M; Dotan A
    Ophthalmic Res; 2023; 66(1):48-56. PubMed ID: 35772382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous Substitutes as Drug Release Systems.
    Schulz A; Szurman P
    Transl Vis Sci Technol; 2022 Sep; 11(9):14. PubMed ID: 36125790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy.
    Nakagawa M; Refojo MF; Marin JF; Doi M; Tolentino FI
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2388-95. PubMed ID: 7591628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology of rabbit eyes with silicone-fluorosilicone copolymer oil as six months internal retinal tamponade.
    Doi M; Refojo MF
    Exp Eye Res; 1995 Oct; 61(4):469-78. PubMed ID: 8549688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative effect of retinoic acid in 1% sodium hyaluronate in an animal model of PVR.
    Takahashi M; Refojo MF; Nakagawa M; Veloso A; Leong FL
    Curr Eye Res; 1997 Jul; 16(7):703-9. PubMed ID: 9222089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathy.
    Chang YC; Hu DN; Wu WC
    Am J Ophthalmol; 2008 Sep; 146(3):440-446. PubMed ID: 18599016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology of rabbit eyes with intravitreous silicone-fluorosilicone copolymer oil.
    Doi M; Refojo MF
    Exp Eye Res; 1994 Dec; 59(6):737-46. PubMed ID: 7698267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proliferative vitreoretinopathy--pathogenesis and therapy].
    Iandiev I; Bringmann A; Wiedemann P
    Klin Monbl Augenheilkd; 2010 Mar; 227(3):168-74. PubMed ID: 20234978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heavy tamponades--background and future perspectives].
    Joussen AM; Kugler W; Lingenfelder C
    Klin Monbl Augenheilkd; 2009 Sep; 226(9):693-8. PubMed ID: 19750417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heavy tamponade 1: a review of indications, use, and complications.
    Heimann H; Stappler T; Wong D
    Eye (Lond); 2008 Oct; 22(10):1342-59. PubMed ID: 18344952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 13-cis-retinoic acid in silicone-fluorosilicone copolymer oil in a rabbit model of proliferative vitreoretinopathy.
    Veloso AA; Kadrmas EF; Larrosa JM; Sandberg MA; Tolentino FI; Refojo MF
    Exp Eye Res; 1997 Sep; 65(3):425-34. PubMed ID: 9299179
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.